FDA drug approval affects healthcare around the world, but political shortcuts could hurt the agency’s international reputation

A new FDA fast-track program could undermine the agency’s role as a global drug safety authority.

By: C. Michael White, University of Connecticut, The Conversation

Outlets: The Conversation

Published: July 15, 2026

Words: 1,364

Last Updated: 5 days, 17 hours ago

By C. Michael White, University of Connecticut

At the beginning of July 2026, the U.S. Food and Drug Administration approved the first gene therapy for young children with sickle cell disease.

While this is good news for children in the U.S. born with this illness, the FDA’s approval may also benefit thousands of children beyond the U.S. border.

…

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.